197 related articles for article (PubMed ID: 3022584)
1. Safety profiles of the angiotensin converting enzyme inhibitors captopril and enalapril.
Irvin JD; Viau JM
Am J Med; 1986 Oct; 81(4C):46-50. PubMed ID: 3022584
[TBL] [Abstract][Full Text] [Related]
2. Lack of cross sensitivity between captopril and enalapril.
Jackson B; Maher D; Matthews PG; McGrath BP; Johnston CI
Aust N Z J Med; 1988 Feb; 18(1):21-7. PubMed ID: 2840055
[TBL] [Abstract][Full Text] [Related]
3. Pharmacology of angiotensin converting enzyme inhibitors. A review.
Nelson EB; Pool JL; Taylor AA
Am J Med; 1986 Oct; 81(4C):13-8. PubMed ID: 3022580
[TBL] [Abstract][Full Text] [Related]
4. Overall tolerance and safety of enalapril.
McFate Smith W; Kulaga SF; Moncloa F; Pingeon R; Walker JF
J Hypertens Suppl; 1984 Dec; 2(2):S113-7. PubMed ID: 6100872
[TBL] [Abstract][Full Text] [Related]
5. Angiotensin-converting enzyme inhibitors: past, present, and bright future.
Edwards CR; Padfield PL
Lancet; 1985 Jan; 1(8419):30-4. PubMed ID: 2856956
[No Abstract] [Full Text] [Related]
6. Adverse reactions with angiotensin converting enzyme (ACE) inhibitors.
DiBianco R
Med Toxicol; 1986; 1(2):122-41. PubMed ID: 3023783
[TBL] [Abstract][Full Text] [Related]
7. Renal effects of angiotensin converting enzyme inhibitors in hypertension.
Bauer JH; Reams GP
Am J Med; 1986 Oct; 81(4C):19-27. PubMed ID: 3022581
[TBL] [Abstract][Full Text] [Related]
8. Clinical utility of angiotensin converting enzyme inhibitors in hypertension.
Gavras I; Gavras H
Am J Med; 1986 Oct; 81(4C):28-31. PubMed ID: 3022582
[TBL] [Abstract][Full Text] [Related]
9. Angiotensin inhibitors for hypertension.
Gavras H; Gavras I; Brunner HR
Compr Ther; 1980 May; 6(5):14-8. PubMed ID: 6155240
[TBL] [Abstract][Full Text] [Related]
10. Renal insufficiency during angiotensin-converting enzyme inhibitor therapy in hypertensive patients with no renal artery stenosis.
Thind GS
J Clin Hypertens; 1985 Dec; 1(4):337-43. PubMed ID: 3014079
[TBL] [Abstract][Full Text] [Related]
11. Comparison of the acute effects of three structurally different converting enzyme inhibitors (captopril, SA-446 and MK-421) on blood pressure, the renin-angiotensin system and the kallikrein-kinin system.
Kondo K; Kida O; Kodama K; Higa T; Someya N; Morotomi Y; Tanaka K
Nihon Jinzo Gakkai Shi; 1985 Mar; 27(3):337-42. PubMed ID: 2991635
[No Abstract] [Full Text] [Related]
12. Monotherapy of hypertension with angiotensin-converting enzyme inhibitors.
Materson BJ
Am J Med; 1984 Oct; 77(4A):128-34. PubMed ID: 6207725
[TBL] [Abstract][Full Text] [Related]
13. Usefulness of patch tests for diagnosing selective allergy to captopril.
Gaig P; San Miguel-Moncin MM; Bartra J; Bonet A; García-Ortega P
J Investig Allergol Clin Immunol; 2001; 11(3):204-6. PubMed ID: 11831455
[TBL] [Abstract][Full Text] [Related]
14. ACE inhibitors captopril and enalapril induce regression of left ventricular hypertrophy in hypertensive patients with chronic renal failure.
Dyadyk AI; Bagriy AE; Lebed IA; Yarovaya NF; Schukina EV; Taradin GG
Nephrol Dial Transplant; 1997 May; 12(5):945-51. PubMed ID: 9175047
[TBL] [Abstract][Full Text] [Related]
15. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075
[TBL] [Abstract][Full Text] [Related]
16. Angiotensin converting enzyme inhibitors and the otolaryngologist.
Cruickshank HE
Clin Otolaryngol Allied Sci; 1995 Jun; 20(3):189-91. PubMed ID: 7554324
[No Abstract] [Full Text] [Related]
17. Effects of intradermal bradykinin after inhibition of angiotensin converting enzyme.
Ferner RE; Simpson JM; Rawlins MD
Br Med J (Clin Res Ed); 1987 May; 294(6580):1119-20. PubMed ID: 3034372
[TBL] [Abstract][Full Text] [Related]
18. Enalapril treatment in a patient with impaired renal function and intolerance to captopril.
Lindsjö M; Danielson BG; Weiss L; Wikström B
Scand J Urol Nephrol Suppl; 1984; 79():99-101. PubMed ID: 6089326
[TBL] [Abstract][Full Text] [Related]
19. [Angiotensin-converting enzyme inhibition: side effects and risks].
Schilling H; Scheler F
Z Kardiol; 1988; 77 Suppl 3():47-54. PubMed ID: 2850687
[TBL] [Abstract][Full Text] [Related]
20. Enalapril, a nonsulfhydryl angiotensin-converting enzyme inhibitor.
Vlasses PH; Larijani GE; Conner DP; Ferguson RK
Clin Pharm; 1985; 4(1):27-40. PubMed ID: 2982541
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]